Psychiatric predictors of long-Term transplant-related outcomes in lung transplant recipients

Transplantation

Volumn 100, Issue 1, 2016, Pages 239-247

  Rosenberger, Emily M ^a   DiMartini, Andrea F ^a   DeVito Dabbs, Annette J ^b   Bermudez, Christian A ^c   Pilewski, Joseph M ^a   Toyoda, Yoshiya ^d   Dew, Mary Amanda ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; BRONCHIOLITIS OBLITERANS; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MORTALITY; POSTOPERATIVE DEPRESSION; PRIORITY JOURNAL; ADVERSE EFFECTS; ANXIETY; DEPRESSIVE DISORDER, MAJOR; EPIDEMIOLOGY; GRAFT RECIPIENT; LUNG TRANSPLANTATION; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PENNSYLVANIA; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PSYCHOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVOR; TIME FACTOR; TREATMENT OUTCOME;

ADULT; ANXIETY; BRONCHIOLITIS OBLITERANS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GRAFT SURVIVAL; HUMANS; LUNG TRANSPLANTATION; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PENNSYLVANIA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVORS; TIME FACTORS; TRANSPLANT RECIPIENTS; TREATMENT OUTCOME;

EID: 84952360275     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000824     Document Type: Article

References (53)

1. Valapour M, Skeans MA, Heubner BM, et al. OPTN/SRTR 2012 Annual Data Report: Lung. Am J Transplant. 2014;14(Suppl 1):139-165.
2. Yusen RD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report-2014; focus theme: retransplantation. J Heart Lung Transplant. 2014;33:1009-1024.
3. Ahmad S, Shlobin OA, Nathan SD. Pulmonary complications of lung transplantation. Chest. 2011;139:402-411.
4. Song MK, DeVito Dabbs AJ, Studer SM, et al. Course of illness after the onset of chronic rejection in lung transplant recipients. Am J Crit Care. 2008;17:246-253.
5. Belperio JA,Weigt SS, Fishbein MC, et al. Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc. 2009;6:108-121.
6. Davis WA, Finlen Copeland CA, Todd JL, et al. Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation. Am J Transplant. 2012;12:745-752.
7. Fiser SM, Tribble CG, Long SM, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg. 2002;73:1041-1047.
8. Dew MA, Cyranowski JM, Pilkonis PA. Medical conditions and depression. In: Ingram RE, ed. The International Encyclopedia of Depression. New York: Springer; 2009:375.
9. Eaton WW, Fogel J, Armenian HK. The consequences of psychopathology in the Baltimore Epidemiologic Catchment Area follow-up. In: Eaton WW, ed. Medical and Psychiatric Comorbidity Over the Course of Life. Washington, DC: American Psychiatric Publishing; 2006:21.
10. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29:147-155.
11. Stein MB, Cox BJ, Afifi TO, et al. Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective. Psychol Med. 2006;36:587-596.
12. Sullivan MD, O'Connor P, Feeney P, et al. Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care. 2012;35:1708-1715.
13. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30:208-225.
14. Sareen J,Cox BJ, Clara I, et al. The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey. Depress Anxiety. 2005;21:193-202.
15. Harter MC, Conway KP, Merikangas KR. Associations between anxiety disorders and physical illness. Eur Arch Psychiatry Clin Neurosci. 2003; 253:313-320.
16. Goetzmann L, Scheuer E, Naef R, et al. Psychosocial situation and physical health in 50 patients > 1 year after lung transplantation. Chest. 2005; 127:166-170.
17. van den Berg J, Geertsma A, van der Bij W, et al. Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life. Am J Respir Crit Care Med. 2000;16:1937-1941.
18. Corbett C, Armstrong MJ, Parker R, et al. Mental health disorders and solid-organ transplant recipients. Transplantation. 2013;96:593-600.
19. Dew MA, DiMartini AF, DeVito Dabbs AJ, et al. Onset and risk factors for anxiety and depression during the first 2 years after lung transplantation. Gen Hosp Psychiatry. 2012;34:127-138.
20. Corruble E, Barry C, Varescon I, et al. Depressive symptoms predict long-Term mortality after liver transplantation. J Psychosom Res. 2011; 71:32-37.
21. DiMartini A, Dew MA, Chaiffetz D, et al. Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-Term survival. Am J Transplant. 2011;11:1287-1295.
22. Novak M, Molnar MZ, Szeifert L, et al. Depressive symptoms andmortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med. 2010;72:527-534.
23. Havik OE, Sivertsen B, Relbo A, et al. Depressive symptoms and all-cause mortality after heart transplantation. Transplantation. 2007;84:97-103.
24. Sirri L, Potena L, Masetti M, et al. Psychological predictors of mortality in heart transplanted patients: a prospective, 6-year follow-up study. Transplantation. 2010;89:879-886.
25. Favaro A, Gerosa G, Caforio AL, et al. Posttraumatic stress disorder and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment. Gen Hosp Psychiatry. 2011;33:1-7.
26. Owen JE, Bonds CL, Wellisch DK. Psychiatric evaluations of heart transplant candidates: predicting posttransplant hospitalizations, rejection episodes, and survival. Psychosomatics. 2006;47:213-222.
27. Rogal SS, Landsittel D, Surman O, et al. Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation. Liver Transpl. 2011;17:251-260.
28. Telles-Correia D, Barbosa A, Mega I, et al. Psychiatric and psychosocial predictors of medical outcome after liver transplantation: a prospective, single-center study. Transplant Proc. 2011;43:155-157.
29. Dobbels F, Skeans MA, Snyder JJ, et al. Depressive disorder in renal transplantation: an analysis of Medicare claims. Am J Kidney Dis. 2008; 51:819-828.
30. Rocha G, Poli de Figueiredo CE, dAvila D, et al. Depressive symptoms and kidney transplant outcome. Transplant Proc. 2001;33:3424.
31. Dew MA, Kormos RL, Roth LH, et al. Early posttransplantmedical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999; 18:549-562.
32. Gries CJ, Dew MA, Curtis JR, et al. Nature and correlates of posttraumatic stress symptomatology in lung transplant recipients. J Heart Lung Transplant. 2013;32:525-532.
33. Goetzmann L, Irani S, Schwegler K, et al. Distress and alexithymia in lung recipients-psychosocial strains and associations with chronic allograft dysfunction. Swiss Med Wkly. 2010;140:382-387.
34. Vermeulen KM, Ten Vergert EM, Verschuuren EA, et al. Pre-Transplant quality of life does not predict survival after lung transplantation. J Heart Lung Transplant. 2008;27:623-627.
35. EvonDM, Burker EJ,Galanko JA, et al. Depressive symptoms andmortality in lung transplant. Clin Transplant. 2010;24:E201-E206.
36. Woodman CL, Geist LJ, Vance S, et al. Psychiatric disorders and survival after lung transplantion. Psychosomatics. 1999;40:293-296.
37. Smith PJ, Blumenthal JA, Carney RM, et al. Neurobehavioral functioning and survival following lung transplantation. Chest. 2014;145:604-611.
38. Rosenberger EM, Dew MA, DiMartini AF, et al. Psychosocial issues facing lung transplant candidates, recipients and family caregivers. Thorac Surg Clin. 2012;22:517-529.
39. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21:297-310.
40. American Psychological Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.).Washington, DC: American Psychiatric Press, Inc.; 2000.
41. First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). Washington, DC: American Psychiatric Press, Inc; 1996 (revised 2002).
42. Shyu S, Dew MA, Pilewski JM, et al. Five-year outcomes with alemtuzumab induction after lung transplantation. J Heart Lung Transplant. 2011;30:743-754.
43. Tabachnick BG, Fidell LS. Using multivariate statistics. 6th ed. Boston: Pearson; 2012.
44. Rogal SS, Dew MA, Fontes P, et al. Early treatment of depressive symptoms and long-Term survival after liver transplantation. Am J Transplant. 2013;13:928-935.
45. Dobbels F, Vanhaecke J, Dupont L, et al. Pretransplant predictors of posttransplant adherence and clinical outcome: an evidence base for pretransplant psychosocial screening. Transplantation. 2009;87: 1497-1504.
46. Dew MA, DiMartini AF, DeVito Dabbs AJ, et al. Adherence to the medical regimen during the first two years after lung transplantation. Transplantation. 2008;85:193-202.
47. Dignam JJ, Kocherginsky MN. Choice and interpretation of statistical tests used when competing risks are present. J Clin Oncol. 2008;26: 4027-4034.
48. Tai BC, Wee J, Machin D. Analysis of design of randomised clinical trials involving competing risks endpoints. Trials. 2011;12:127.
49. Beck AT, Steer RA, Brown CK. Beck Depression Inventory-Second Edition Manual. SanAntonio, TX: PsychologicalCorp, Harcourt Brace Jovanovich; 1986.
50. Kroenke K, Spitzer RL,Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-613.
51. Spielberger CD, Gorsuch RL, Lushene R, et al. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
52. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166: 1092-1097.
53. Hackman KL, Bailey MJ, Snell GI, et al. Diabetes is a major risk factor for mortality after lung transplantation. Am J Transplant. 2014;14:438-445.